Fresenius Medical Care Sets 2024 AGM Date

Ticker: FMCQF · Form: 6-K · Filed: Mar 28, 2024 · CIK: 1333141

Fresenius Medical Care Ag 6-K Filing Summary
FieldDetail
CompanyFresenius Medical Care Ag (FMCQF)
Form Type6-K
Filed DateMar 28, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: agm, shareholder-meeting, filing-update

TL;DR

FMC set its 2024 AGM for May 16th, agenda posted.

AI Summary

Fresenius Medical Care AG announced on March 28, 2024, the invitation and agenda for its 2024 Annual General Meeting (AGM) scheduled for May 16, 2024. A translated version of the AGM materials is available on the company's website.

Why It Matters

Shareholders will vote on key company matters at the AGM, influencing the company's future direction and strategy.

Risk Assessment

Risk Level: low — This filing is a routine announcement of an upcoming shareholder meeting and does not contain new financial or operational risks.

Key Players & Entities

  • Fresenius Medical Care AG (company) — Registrant
  • May 16, 2024 (date) — Date of 2024 Annual General Meeting
  • March 28, 2024 (date) — Date of announcement and filing

FAQ

When is the Fresenius Medical Care AG 2024 Annual General Meeting?

The 2024 Annual General Meeting is scheduled to be held on May 16, 2024.

Where can shareholders find the agenda for the 2024 AGM?

The agenda for the 2024 AGM has been published in the German Bundesanzeiger and a convenience translation is available on the company's website at www.freseniusmedicalcare.com/en/agm.

What type of filing is this for Fresenius Medical Care AG?

This is a Form 6-K filing, which is a Report of Foreign Private Issuer.

What is the Commission file number for Fresenius Medical Care AG?

The Commission file number for Fresenius Medical Care AG is 001-32749.

What is the principal executive office address for Fresenius Medical Care AG?

The principal executive offices are located at Else-Kröner Strasse 1, 61346 Bad Homburg, Germany.

Filing Stats: 673 words · 3 min read · ~2 pages · Grade level 15 · Accepted 2024-03-28 17:14:14

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: March 28, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.